We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$1.52B
AUM Growth
-$7.28B
Cap. Flow
-$6.76B
Cap. Flow %
-444.29%
Top 10 Hldgs %
100%
Holding
929
New
Increased
6
Reduced
3
Closed
920

Sector Composition

Rank Sector Weight
1 Technology 45.54%
2 Healthcare 36.97%
3 Financials 14.43%
4 Communication Services 3.06%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MACC
851
DELISTED
Mission Advancement Corp.
MACC
-139,692
Closed -$1.37M
RACB
852
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
-95,450
Closed -$937K
REVH
853
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Class A Common Stock
REVH
-619,304
Closed -$6.09M
SWCH
854
DELISTED
Switch, Inc. Class A Common Stock
SWCH
-8,043,107
Closed -$271M
NDAC
855
DELISTED
NightDragon Acquisition Corp. Class A Common stock
NDAC
-380,556
Closed -$3.74M
ACII
856
DELISTED
Atlas Crest Investment Corp. II
ACII
-238,001
Closed -$2.35M
OHPA
857
DELISTED
Orion Acquisition Corp. Class A common stock
OHPA
-467,544
Closed -$4.6M
SWET
858
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
-403,764
Closed -$3.99M
TMAC
859
DELISTED
The Music Acquisition Corporation
TMAC
-604,187
Closed -$5.96M
SWETW
860
DELISTED
Athlon Acquisition Corp. Warrant
SWETW
-225,737
Closed -$8K
TSIB
861
DELISTED
Tishman Speyer Innovation Corp. II Class A common stock
TSIB
-236,438
Closed -$2.33M
LMACA
862
DELISTED
Liberty Media Acquisition Corporation Series A Common Stock
LMACA
-234,694
Closed -$2.33M
CRU
863
DELISTED
Crucible Acquisition Corporation
CRU
-475,337
Closed -$4.73M
PHIC
864
DELISTED
Population Health Investment Co., Inc. Class A Ordinary Share
PHIC
-263,188
Closed -$2.63M
SBII
865
DELISTED
Sandbridge X2 Corp.
SBII
-639,698
Closed -$6.29M
EQHA.WS
866
DELISTED
EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
EQHA.WS
-196,703
Closed -$17K
FRW
867
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
-237,848
Closed -$2.34M
ASZ
868
DELISTED
Austerlitz Acquisition Corporation II
ASZ
-1,902,126
Closed -$18.7M
FVT
869
DELISTED
Fortress Value Acquisition Corp. III
FVT
-712,856
Closed -$7.06M
FVIV
870
DELISTED
Fortress Value Acquisition Corp. IV
FVIV
-499,404
Closed -$4.91M
AUS
871
DELISTED
Austerlitz Acquisition Corporation I
AUS
-567,051
Closed -$5.56M
CLR
872
DELISTED
CONTINENTAL RESOURCES INC.
CLR
-596,111
Closed -$39.8M
ZEN
873
DELISTED
ZENDESK INC
ZEN
-5,997,102
Closed -$456M
IACC
874
DELISTED
ION Acquisition Corp 3 Ltd.
IACC
-951,516
Closed -$9.39M
ATAQ.WS
875
DELISTED
Altimar Acquisition Corp III Warrants
ATAQ.WS
-95,140
Closed -$12K

Similar funds

UBS O'Connor's Q4 2022 Portfolio in Review

As of Q4 2022, UBS O'Connor held 929 positions worth $1.52B, down 83% from $8.8B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

UBS O'Connor withdrew a net $6.76B in Q4 2022, closing 920 positions and reducing 3 holdings. Its most notable exit was Biohaven Pharmaceutical Holding Company Ltd., an estimated $572M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 28% a quarter earlier, followed by Healthcare and Financials.

Against the trend, UBS O'Connor added an estimated $184M to Horizon Therapeutics Public Limited Company Ordinary Shares.

  • UBS O'Connor added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022, an estimated $184M increase.
  • UBS O'Connor's biggest Q4 2022 reduction was Activision Blizzard, cutting an estimated $45.3M.
  • UBS O'Connor fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $572M.
  • UBS O'Connor's ten largest holdings make up 100% of its $1.52B portfolio in Q4 2022.
  • UBS O'Connor opened 0 new positions and closed 920 in Q4 2022.
  • UBS O'Connor's portfolio value fell 83% quarter-over-quarter to $1.52B.

Based on UBS O'Connor's 13F filing for Q4 2022, filed 14 Feb 2023.